These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37787960)

  • 21. Development and Validation of a Prognostic Model for Esophageal Adenocarcinoma Based on Necroptosis-Related Genes.
    Zhang S; Liu S; Lin Z; Zhang J; Lin Z; Fang H; Hu Z
    Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi-omics analysis revealing a senescence-relevant lncRNAs signature for the assessment of response to immunotherapy for breast cancer.
    Yu Z; Zhu Y; Ji J
    Medicine (Baltimore); 2023 Jul; 102(28):e34287. PubMed ID: 37443486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel necroptosis-related long noncoding RNA model for predicting clinical features, immune characteristics, and therapeutic response in clear cell renal cell carcinoma.
    Zhang L; Chen Y; Hu W; Wu B; Ye L; Wang D; Bai T
    Front Immunol; 2023; 14():1230267. PubMed ID: 37600792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of necroptosis-related gene signature and characterization of tumour microenvironment infiltration in non-small-cell lung cancer.
    Dai J; Fu Y
    J Cell Mol Med; 2022 Sep; 26(17):4698-4709. PubMed ID: 35871768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and validation of necroptosis-related gene signatures to predict clinical outcomes and therapeutic responses in acute myeloid leukemia.
    Wen XM; Xu ZJ; Ma JC; Xia PH; Jin Y; Chen XY; Qian W; Lin J; Qian J
    Aging (Albany NY); 2023 Nov; 15(24):14677-14702. PubMed ID: 37993258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of Bladder Cancer Subtypes Based on Necroptosis-Related Genes, Construction of a Prognostic Model.
    Nie S; Huili Y; He Y; Hu J; Kang S; Cao F
    Front Surg; 2022; 9():860857. PubMed ID: 35478725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive analysis of cuproptosis-related genes and tumor microenvironment infiltration characterization in breast cancer.
    Song S; Zhang M; Xie P; Wang S; Wang Y
    Front Immunol; 2022; 13():978909. PubMed ID: 36341328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of necroptosis subtypes and development of necroptosis-related risk score model for in ovarian cancer.
    Ji C; He Y; Wang Y
    Front Genet; 2022; 13():1043870. PubMed ID: 36568363
    [No Abstract]   [Full Text] [Related]  

  • 29. Crosstalk of necroptosis and pyroptosis defines tumor microenvironment characterization and predicts prognosis in clear cell renal carcinoma.
    Fu L; Bao J; Li J; Li Q; Lin H; Zhou Y; Li J; Yan Y; Langston ME; Sun T; Guo S; Zhou X; Chen Y; Liu Y; Zhao Y; Lu J; Huang Y; Chen W; Chung BI; Luo J
    Front Immunol; 2022; 13():1021935. PubMed ID: 36248876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A necroptosis -related signature for predicting prognosis and immunotherapy in hepatocellular carcinoma.
    Fu X; Yang Y; Zhang X
    Front Genet; 2022; 13():919599. PubMed ID: 36134033
    [No Abstract]   [Full Text] [Related]  

  • 31. A comprehensive pan-cancer analysis of necroptosis molecules in four gynecologic cancers.
    Zheng J; Cai X; Zhang Y; Wang H; Liu L; Tang F; Liu L; Sun Y
    BMC Cancer; 2022 Nov; 22(1):1160. PubMed ID: 36357839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunotherapy landscape analyses of necroptosis characteristics for breast cancer patients.
    Yu H; Lv W; Tan Y; He X; Wu Y; Wu M; Zhang Q
    J Transl Med; 2022 Jul; 20(1):328. PubMed ID: 35864548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leveraging single-cell sequencing analysis and bulk-RNA sequencing analysis to forecast necroptosis in cutaneous melanoma prognosis.
    Xie J; Zhang P; Tang Q; Ma C; Li M; Qi M
    Exp Dermatol; 2024 Jul; 33(7):e15148. PubMed ID: 39051739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and validation of a necroptosis-related gene prognostic score to predict prognosis and efficiency of immunotherapy in gastric cancer.
    Xia Y; Zhang R; Wang M; Li J; Dong J; He K; Guo T; Ju X; Ru J; Zhang S; Sun Y
    Front Immunol; 2022; 13():977338. PubMed ID: 36159818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A four-gene signature in the tumor microenvironment that significantly associates with the prognosis of patients with breast cancer.
    Wang J; Yang Z; Zhang C; Ouyang J; Zhang G; Wu C
    Gene; 2020 Nov; 761():145049. PubMed ID: 32791092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Model Associated with Necroptosis in Colorectal Cancer based on Transcriptomic Analysis and Experimental Validation.
    Huang Y; Li L; Kang Z; Luo H; Lin X; Zhao S; Zhang Q; Li Q; Liu H; Li M
    Front Biosci (Landmark Ed); 2024 Mar; 29(3):98. PubMed ID: 38538261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pyroptosis, apoptosis, and necroptosis molecular subtype derived prognostic signature universal applicable for gastric cancer-A large sample and multicenter retrospective analysis.
    Huo J; Xie W; Fan X; Sun P
    Comput Biol Med; 2022 Oct; 149():106037. PubMed ID: 36044785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of Necroptosis-related Subtypes and Characterization of Tumor Microenvironment Infiltration in Non-small Cell Lung Cancer.
    Deng Y; Lin Y; Zhou B; Jing Q; Zhang W
    Curr Cancer Drug Targets; 2023 Jun; ():. PubMed ID: 37469156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Necroptosis-related lncRNA signatures determine prognosis in breast cancer patients.
    Zhang Y; Yue Q; Cao F; Li Y; Wei Y
    Sci Rep; 2022 Jul; 12(1):11268. PubMed ID: 35787661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and Verification of Necroptosis-Related Gene Signature With Prognosis and Tumor Immune Microenvironment in Ovarian Cancer.
    Wang Z; Chen G; Dai F; Liu S; Hu W; Cheng Y
    Front Immunol; 2022; 13():894718. PubMed ID: 35812403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.